Ryufin

NAMSNewAmsterdam Pharma Company N.V.

$34.90

$18.1152W$41.45

Price

$34.90+72.45%1Y

1M-12.13%1Y+72.45%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Lagging

1/10

Value20

Quality18

Momentum46

Growth26

Strongest Momentum, weakest Quality · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

P/E (TTM)-

Market Cap$3.71B

1Y Return+72.45%

5Y Return+225.44%

Ranks #331 of 351 in Healthcare by Smart Score